Quality Control Analysis Using the Failure Mode and Effect Analysis Method

Muchammad Lukman Hakim, A. S. Cahyana
{"title":"Quality Control Analysis Using the Failure Mode and Effect Analysis Method","authors":"Muchammad Lukman Hakim, A. S. Cahyana","doi":"10.21070/pels.v7i0.1589","DOIUrl":null,"url":null,"abstract":"This study aimed to investigate critical factors contributing to defective Epodion® rh-Erythropoietin Alfa syringes, specifically focusing on reducing cracks during manufacturing. A Failure Mode and Effect Analysis (FMEA) approach was employed to identify the primary causes of failure, revealing cracking as the predominant issue affecting 43% of defective units. To mitigate this concern, we calculated a Risk Priority Number (RPN) of 162, highlighting the significance of addressing material-related issues. By recommending enhanced quality control measures for raw materials prior to their utilization within the production process, our findings suggest potential improvements in material strength, thereby minimizing product defects \nHighlight : \n \nThe study aimed to investigate factors contributing to defective Epodion® rh-Erythropoietin Alfa syringes, with a focus on reducing cracks during manufacturing. \nA Failure Mode and Effect Analysis (FMEA) approach was used to identify the primary causes of failure, revealing cracking as the predominant issue affecting 43% of defective units. \nEnhanced quality control measures for raw materials prior to their utilization within the production process were recommended to minimize product defects. \n \nKeywords: Epodion, rh-Erythropoietin Alfa, syringes, FMEA, quality control.","PeriodicalId":491073,"journal":{"name":"Procedia of Engineering and Life Science","volume":"7 5","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Procedia of Engineering and Life Science","FirstCategoryId":"0","ListUrlMain":"https://doi.org/10.21070/pels.v7i0.1589","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

This study aimed to investigate critical factors contributing to defective Epodion® rh-Erythropoietin Alfa syringes, specifically focusing on reducing cracks during manufacturing. A Failure Mode and Effect Analysis (FMEA) approach was employed to identify the primary causes of failure, revealing cracking as the predominant issue affecting 43% of defective units. To mitigate this concern, we calculated a Risk Priority Number (RPN) of 162, highlighting the significance of addressing material-related issues. By recommending enhanced quality control measures for raw materials prior to their utilization within the production process, our findings suggest potential improvements in material strength, thereby minimizing product defects Highlight : The study aimed to investigate factors contributing to defective Epodion® rh-Erythropoietin Alfa syringes, with a focus on reducing cracks during manufacturing. A Failure Mode and Effect Analysis (FMEA) approach was used to identify the primary causes of failure, revealing cracking as the predominant issue affecting 43% of defective units. Enhanced quality control measures for raw materials prior to their utilization within the production process were recommended to minimize product defects. Keywords: Epodion, rh-Erythropoietin Alfa, syringes, FMEA, quality control.
使用失效模式与影响分析法进行质量控制分析
本研究旨在调查导致 Epodion® rh-Erythropoietin Alfa 注射器出现缺陷的关键因素,尤其侧重于减少生产过程中的裂纹。我们采用了失效模式和影响分析 (FMEA) 方法来确定失效的主要原因,结果发现裂纹是影响 43% 缺陷产品的主要问题。为了减少这一问题,我们计算出的风险优先值 (RPN) 为 162,突出了解决材料相关问题的重要性。通过建议在生产过程中使用原材料之前加强对原材料的质量控制措施,我们的研究结果表明了提高材料强度的可能性,从而最大限度地减少产品缺陷。 该研究旨在调查造成 Epodion® rh-Erythropoietin Alfa 注射器缺陷的因素,重点是减少生产过程中的裂纹。研究采用了失效模式和影响分析 (FMEA) 方法来确定失效的主要原因,结果发现裂纹是主要问题,影响了 43% 的缺陷产品。建议在生产过程中使用原材料之前加强质量控制措施,以尽量减少产品缺陷。 关键词Epodion、rh-促红细胞生成素α、注射器、FMEA、质量控制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信